✦ LIBER ✦

Argon laser therapy for perianal Bowen's disease: A case report

✍ Scribed by Kathleen K. Boynton; David J. Bjorkman

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 289 KB
Volume: 11
Category: Article
ISSN: 0196-8092
DOI: 10.1002/lsm.1900110412

No coin nor oath required. For personal study only.

✦ Synopsis

Bowen's disease (intraepithelial squamous cell carcinoma) may occasionally occur in anal canal or perianal region. Surgical excision in this area may result in significant complications and a recurrence rate of 9-19%.

A case of successful treatment of anal and perianal Bowen's disease using argon laser therapy is presented. No acute or chronic complications resulted from laser therapy. Twenty-eight months after the initial diagnosis the patient is disease free. Laser therapy also provides the potential for repeated treatment of recurrent lesions without significant patient discomfort or inconvenience. Argon laser therapy should be considered as a therapeutic option in the treatment of Bowen's disease.

📜 SIMILAR VOLUMES

Everolimus for refractory Crohn's diseas

Everolimus for refractory Crohn's disease: A case report

✍ Jérôme Dumortier; Marie-George Lapalus; Olivier Guillaud; Gilles Poncet; Marie-C 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

Case report of aseptic meningitis in a p

Case report of aseptic meningitis in a patient with Crohn's disease under infliximab therapy

✍ Carolin Manthey; Ansgar W. Lohse; Andrea Pace 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 2 views

Long-term remission in hodgkin's disease

Long-term remission in hodgkin's disease after nitrogen mustard therapy. Report of a Case

✍ Joseph M. Kiely; Edgar G. Harrison JR. 📂 Article 📅 1970 🏛 John Wiley and Sons 🌐 English ⚖ 762 KB

A patient with Hodgkin's disease (Stage IIB) was given nitrogen mustard shortly after diagnosis and has survived, without recurrence, for more than 5 years. HFhfOTHERAPY FOR CANCER IS OFTEN OF C palliative benefit but is only rarely curative. Single-agent chemotherapy4, 5 , 9 has achieved cure rate

Adverse reaction after tetrathiomolybdat

Adverse reaction after tetrathiomolybdate treatment for Wilson's disease: A case report

✍ Valentina Medici; Carlo Pietro Trevisan; Maria Assunta Bigotto; Renata D'Incà; D 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

muscle: 36.6 U; mean total dosage per session: 282.2 U). In 83.8% of these patients, we injected more than 4 muscles, with a mean of 8.5 treated muscles (mean dosages per kg body weight: 17.9 U; range: 5.1-32.3 U; mean dosage per muscle: 35.6 U; mean total dosage per session: 303.0 U). The data are

De Quervain's disease: A plea for early

De Quervain's disease: A plea for early operation. A report on 40 cases

✍ T. H. E. Woods 📂 Article 📅 1964 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 1 views

Pityriasis lichenoides chronica induced

Pityriasis lichenoides chronica induced by adalimumab therapy for Crohn's disease: Report of 2 cases successfully treated with methotrexate

✍ B. Ben Said; J. Kanitakis; I. Graber; J.F. Nicolas; J.C. Saurin; F. Berard 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

Tumor necrosis factor alpha (TNF-a) inhibitors improve inflammatory diseases such as Crohn's disease (CD). However, these biologicals may induce infections, neoplasms, or autoimmune diseases. Cutaneous side effects have been reported, including dermatitis, psoriasis-like rash, and vasculitis. 1 We r